– USA, UT – R-Zero, a global leader in biosafety technology, today announced the appointment of Jennifer Nuckles as CEO and the Chair of the Board of Directors, effective October 10.
“With the world today transforming, R-Zero has a massive market opportunity to help organizations deliver on the promise of safety and productivity,” said co-founder, Ben Boyer. “R-Zero has already demonstrated extremely rapid growth, and with Jennifer’s leadership, the company will accelerate even further. Jennifer uniquely possesses a founder’s mindset, a passion for our mission, a deep commitment to customer success, and a track record of execution at scale. I am excited to have Jennifer leading R-Zero through its next chapter of growth.”
About Jennifer Nuckles
Jennifer Nuckles is an industry veteran with over 25 years of experience leading and accelerating revenue growth and profitability for companies, including high-growth, venture-backed and public companies. Jennifer Nuckles will join R-Zero from SoFi, where she is EVP and Group Business Leader over multiple enterprise businesses. Prior to SoFi, Nuckles was CMO of health tech leader Doctor on Demand and social gaming giant Zynga, Inc. In addition, she spent almost a decade in leadership positions at The Clorox Company in marketing and sales.
“I’m excited to help impact the company’s next phase of growth as R-Zero becomes the obvious choice for enterprises looking for validated, efficacious, and efficient solutions to help protect their most valuable asset of all – their people,” said Jennifer Nuckles. “I have tremendous admiration for the R-Zero team and the business they have built thus far, and I’m looking forward to working with the team, our network of partners, and our customers to positively impact our shared spaces and, ultimately, our shared humanity.”
About R-Zero
R-Zero is the first biosafety technology company dedicated to making our shared indoor spaces safer, healthier, and more productive. Backed by Mayo Clinic and the earliest investors in Google, Amazon, Tesla, and SpaceX, R-Zero is dedicated to developing the most effective and innovative disinfection technologies to reduce the spread of microorganisms in the built environment. Combining space utilization sensor technology, AI, ML, and IoT-connected hardware, R-Zero’s intelligent biosafety platform enables organizations to create and maintain healthier indoor environments. Today, the company’s sustainable, IoT-enabled disinfection technologies enable safer, healthier indoor spaces for hundreds of thousands of people across both public and private sector organizations without using chemicals. R-Zero’s system of connected biosafety technologies provides greater visibility, automation, and even smarter risk reduction within the indoor spaces where people spend their time. Among its investors, R-Zero counts leading venture capital firms DBL Partners, World Innovation Lab, and SOSV/HAX; and thought leaders from hospitality, sports, commercial real estate, and other industries.
For more information: https://www.rzero.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.